{"id":"https://openalex.org/W4367304733","doi":"https://doi.org/10.1212/wnl.0000000000203941","title":"Effects of Solriamfetol on Cognitive Function in Participants with Cognitive Impairment Associated with Excessive Daytime Sleepiness in Obstructive Sleep Apnea: Results of the SHARP Study (P4-13.004)","display_name":"Effects of Solriamfetol on Cognitive Function in Participants with Cognitive Impairment Associated with Excessive Daytime Sleepiness in Obstructive Sleep Apnea: Results of the SHARP Study (P4-13.004)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304733","doi":"https://doi.org/10.1212/wnl.0000000000203941"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000203941","doi":"https://doi.org/10.1212/wnl.0000000000203941","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203941","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036030045","display_name":"Hans Van Dongen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I72951846","display_name":"Washington State University","ror":"https://ror.org/05dk0ce17","country_code":"US","type":"education","lineage":["https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans Van Dongen","raw_affiliation_strings":["Translational Medicine and Physiology; Sleep and Performance Research Center, Washington State University","Translational Medicine and Physiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Physiology; Sleep and Performance Research Center, Washington State University","institution_ids":["https://openalex.org/I72951846"]},{"raw_affiliation_string":"Translational Medicine and Physiology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073097180","display_name":"Eileen B. Leary","orcid":"https://orcid.org/0000-0002-7389-6384","observed_orcids":["https://orcid.org/0000-0002-7389-6384"]},"institutions":[{"id":"https://openalex.org/I4210101297","display_name":"Jazz Pharmaceuticals (United States)","ror":"https://ror.org/019rsbe67","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101297","https://openalex.org/I4210152300"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eileen Leary","raw_affiliation_strings":["Jazz Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jazz Pharmaceuticals","institution_ids":["https://openalex.org/I4210101297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060026372","display_name":"Christopher Lawrence Drake","orcid":"https://orcid.org/0000-0002-5486-3587","observed_orcids":["https://orcid.org/0000-0002-5486-3587"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Drake","raw_affiliation_strings":["Henry Ford Health System"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084367532","display_name":"Richard Bogan","orcid":"https://orcid.org/0000-0001-7043-2974","observed_orcids":["https://orcid.org/0000-0001-7043-2974"]},"institutions":[{"id":"https://openalex.org/I4210154614","display_name":"SleepMed","ror":"https://ror.org/04bxj6908","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210154614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Bogan","raw_affiliation_strings":["SleepMed"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SleepMed","institution_ids":["https://openalex.org/I4210154614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006572593","display_name":"Judith Jaeger","orcid":"https://orcid.org/0000-0002-3396-5402","observed_orcids":["https://orcid.org/0000-0002-3396-5402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith Jaeger","raw_affiliation_strings":["CognitionMetrics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CognitionMetrics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082868877","display_name":"Russell P. Rosenberg","orcid":"https://orcid.org/0000-0002-6463-0082","observed_orcids":["https://orcid.org/0000-0002-6463-0082"]},"institutions":[{"id":"https://openalex.org/I4210149960","display_name":"NeuroTrials Research (United States)","ror":"https://ror.org/044jq0109","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149960"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell Rosenberg","raw_affiliation_strings":["Neurotrials Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotrials Research","institution_ids":["https://openalex.org/I4210149960"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045156395","display_name":"Caroline Streicher","orcid":"https://orcid.org/0000-0002-1230-738X","observed_orcids":["https://orcid.org/0000-0002-1230-738X","https://orcid.org/0009-0007-7777-2454"]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Streicher","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103222359","display_name":"Hannah Kwak","orcid":"https://orcid.org/0009-0004-8509-046X","observed_orcids":["https://orcid.org/0009-0004-8509-046X"]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Kwak","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113470136","display_name":"Jay Bates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay Bates","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073345392","display_name":"Herriot Tabuteau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herriot Tabuteau","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10234","display_name":"Obstructive Sleep Apnea Research","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10234","display_name":"Obstructive Sleep Apnea Research","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11373","display_name":"Sleep and Work-Related Fatigue","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solriamfetol","display_name":"solriamfetol","score":1.0},{"id":"https://openalex.org/keywords/obstructive-sleep-apnea","display_name":"obstructive sleep apnea","score":0.875},{"id":"https://openalex.org/keywords/excessive-daytime-sleepiness","display_name":"excessive daytime sleepiness","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.9929999709129333},{"id":"https://openalex.org/keywords/wakefulness-promoting-drugs","display_name":"wakefulness-promoting drugs","score":0.6489999890327454},{"id":"https://openalex.org/keywords/taar1","display_name":"TAAR1","score":0.7459999918937683},{"id":"https://openalex.org/keywords/digit-symbol-substitution-test","display_name":"Digit Symbol Substitution Test","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cognitive-complaints","display_name":"cognitive complaints","score":0.6330000162124634},{"id":"https://openalex.org/keywords/epworth-sleepiness-scale","display_name":"Epworth Sleepiness Scale","score":0.8899999856948853},{"id":"https://openalex.org/keywords/intermittent-hypoxia","display_name":"intermittent hypoxia","score":0.6290000081062317},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4090000092983246},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C162725370","wikidata":"https://www.wikidata.org/wiki/Q52643","display_name":"Daytime","level":2,"score":0.8492047190666199},{"id":"https://openalex.org/C2776006263","wikidata":"https://www.wikidata.org/wiki/Q16606552","display_name":"Obstructive sleep apnea","level":2,"score":0.7875467538833618},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.6910587549209595},{"id":"https://openalex.org/C2781433485","wikidata":"https://www.wikidata.org/wiki/Q3144201","display_name":"Excessive daytime sleepiness","level":4,"score":0.6651884317398071},{"id":"https://openalex.org/C548259974","wikidata":"https://www.wikidata.org/wiki/Q569965","display_name":"Audiology","level":1,"score":0.5519657135009766},{"id":"https://openalex.org/C2984915365","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive impairment","level":3,"score":0.5514755845069885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5384021401405334},{"id":"https://openalex.org/C2777935920","wikidata":"https://www.wikidata.org/wiki/Q213600","display_name":"Sleep apnea","level":2,"score":0.5214354395866394},{"id":"https://openalex.org/C2781326671","wikidata":"https://www.wikidata.org/wiki/Q754424","display_name":"Apnea","level":2,"score":0.4174753427505493},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4061703383922577},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3502260446548462},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.29409778118133545},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25548332929611206},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20650872588157654},{"id":"https://openalex.org/C1513209611","wikidata":"https://www.wikidata.org/wiki/Q177190","display_name":"Sleep disorder","level":3,"score":0.1589493453502655},{"id":"https://openalex.org/C91586092","wikidata":"https://www.wikidata.org/wiki/Q757520","display_name":"Atmospheric sciences","level":1,"score":0.04885303974151611},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.04161235690116882}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000203941","doi":"https://doi.org/10.1212/wnl.0000000000203941","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203941","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4378652209","https://openalex.org/W4394976639","https://openalex.org/W4281719726","https://openalex.org/W4404206687","https://openalex.org/W4402605134","https://openalex.org/W4410135263","https://openalex.org/W4394600133","https://openalex.org/W7164161294","https://openalex.org/W4410503110","https://openalex.org/W4391771485"],"abstract_inverted_index":{"Objective:":[0],"The":[1,166,212,264,484,495,506,517,694,706,718,729,740,751,762,773,784,865],"SHARP":[2,119],"study":[3,213],"evaluated":[4],"whether":[5],"solriamfetol":[6,104,142,270],"improves":[7],"cognitive":[8,137,290],"function":[9,291],"in":[10,40,66,93,127,292,310,330,349,375,408,424,433,451,470,547,571,595,619,643,662,681,852,895,916,937,960],"patients":[11,68,129,140,293],"with":[12,18,69,72,95,98,130,133,158,232,269,294,297,362,385,820],"excessive":[13],"daytime":[14],"sleepiness":[15],"(EDS)":[16],"associated":[17,71,97,132,296],"obstructive":[19],"sleep":[20,42,54],"apnea":[21],"(OSA)":[22],"and":[23,43,52,78,81,108,135,153,205,254,277,286,299],"extant":[24],"impaired":[25,300],"cognition.":[26,117,301],"Background:":[27],"OSA":[28,134,298],"is":[29,62,88,825],"a":[30,63,121,163,318,338,357,383,416,441,459,478,535,555,579,603,627,651,670,689,803,814,818,860,1000],"common":[31,266],"disorder":[32],"characterized":[33],"by":[34,148,162],"repeated":[35],"intermittent":[36],"hypoxic":[37,50],"events":[38,51,268],"resulting":[39],"disrupted":[41],"EDS.":[44],"Positive":[45],"Airway":[46],"Pressure":[47],"(PAP)":[48],"reduces":[49],"mitigates":[53],"disruption,":[55],"but":[56],"EDS":[57,70,96,131,295],"often":[58],"persists.":[59],"Cognitive":[60,201],"impairment":[61],"burdensome":[64],"symptom":[65],"many":[67],"OSA,":[73],"which":[74],"leads":[75],"to":[76,90,226,538,808,827,1005],"occupational":[77],"social":[79],"dysfunction":[80],"degrades":[82],"quality":[83],"of":[84,180,187,238,289,313,333,352,365,378,399,411,436,454,473,486,497,508,519,550,574,598,622,646,665,684,696,708,720,731,742,753,764,775,786,843,855,867,888,909,930,951,963,972,975],"life.":[85],"Solriamfetol":[86,218,240,281],"(Sunosi\u00ae)":[87],"approved":[89],"improve":[91],"wakefulness":[92],"adults":[94],"OSA.":[99],"In":[100],"nonclinical":[101],"pharmacology":[102],"studies,":[103],"inhibited":[105],"dopamine/norepinephrine":[106],"reuptake":[107],"activated":[109],"trace":[110],"amine-associated":[111],"receptor":[112],"1":[113],"(TAAR1),":[114],"potentially":[115],"benefiting":[116],"Design/Methods:":[118],"was":[120,169,216],"randomized,":[122],"double-blind,":[123],"placebo-controlled,":[124],"crossover":[125],"trial":[126],"59":[128],"demonstrated":[136],"impairment.":[138],"All":[139],"received":[141,307,327,346,372,391,405,430,448,467,490,501,512,523,531,544,568,592,616,640,659,678,700,712,724,735,746,757,768,779,790,798,835,849,871,880,901,922,943,957,983,995],"(75mg":[143],"for":[144,150,155,184,315,320,335,340,354,380,394,413,418,438,443,456,462,475,481,552,563,576,587,600,611,624,635,648,654,667,673,686,692,838,857,863,883,904,925,946,965,977],"3":[145],"days":[146],"followed":[147],"150mg/day)":[149],"2":[151,156],"weeks,":[152,157],"placebo":[154,227],"treatment":[159,219,241,271],"periods":[160],"separated":[161],"1-week":[164],"washout.":[165],"primary":[167],"endpoint":[168],"change":[170,194],"from":[171,195,493,504,515,526,534,703,715,727,738,749,760,771,782,793,802,874,989,999],"baseline":[172,196],"on":[173,197,222,245,458,477,554,578,602,626,650,669,688,859],"the":[174,181,185,198,206,223,246,255,311,331,350,376,409,434,452,471,548,572,596,620,644,663,682,853,961,973],"Digit":[175],"Symbol":[176],"Substitution":[177],"Test":[178],"equivalent":[179],"Repeatable":[182],"Battery":[183],"Assessment":[186],"Neuropsychological":[188],"Status":[189],"(DSST-RBANS).":[190],"Secondary":[191],"endpoints":[192],"included":[193],"British":[199],"Columbia":[200],"Complaints":[202],"Inventory":[203],"(BC-CCI)":[204],"Epworth":[207],"Sleepiness":[208],"Scale":[209],"(ESS).":[210],"Results:":[211],"completion":[214],"rate":[215],"96.7%.":[217],"improved":[220,283],"performance":[221],"DSST-RBANS":[224],"compared":[225],"(6.49":[228],"vs.":[229],"4.75,":[230],"p=0.009),":[231],"an":[233,397,841,886,907,928,949,968,986],"effect":[234],"size":[235],"(Cohen\u2019s":[236],"d)":[237],"0.36.":[239],"also":[242],"yielded":[243],"improvements":[244],"BC-CCI":[247],"(\u22124.70":[248],"vs":[249,258],"\u22123.11,":[250],"p=0.002;":[251],"d":[252,261],"=0.43)":[253],"ESS":[256],"(\u22124.41":[257],"\u22122.31,":[259],"p=0.004;":[260],"=":[262],"0.50).":[263],"most":[265],"adverse":[267],"(incidence":[272],"\u22653%)":[273],"were":[274],"nausea":[275],"(6.9%)":[276],"anxiety":[278],"(3.4%).":[279],"Conclusions:":[280],"(150mg/day)":[282],"both":[284],"objective":[285],"subjective":[287],"measures":[288],"Disclosure:":[302],"Prof.":[303,323,342,368],"Van":[304,324,343,369],"Dongen":[305,325,344,370],"has":[306,326,345,371,390,404,422,429,447,466,489,500,511,522,530,543,567,591,615,639,658,677,699,711,723,734,745,756,767,778,789,797,813,834,848,870,879,893,900,914,921,935,942,956,982,994],"personal":[308,328,347,373,392,406,431,449,468,545,569,593,617,641,660,679,836,850,881,902,923,944,958],"compensation":[309,329,348,374,393,407,432,450,469,546,570,594,618,642,661,680,837,851,882,903,924,945,959],"range":[312,332,351,377,410,435,453,472,549,573,597,621,645,664,683,854,962],"$5,000-$9,999":[314,551,647,666],"serving":[316,336,355,381,395,414,439,457,476,553,577,601,625,649,668,687,839,858,884,905,926,947,966],"as":[317,337,356,382,396,415,440,817,840,885,906,927,948,967],"Consultant":[319,339,417,442],"Jazz":[321,400,425,704],"Pharmaceuticals.":[322,401,426,705],"$500-$4,999":[334,353,437,599,623,856],"Eisai.":[341,444,463,739,864],"speaker":[358],"at":[359],"virtual":[360],"meeting":[361],"American":[363],"Academy":[364],"Sleep":[366,822],"Medicine.":[367],"$0-$499":[379,964],"reviewer":[384],"AAA":[386],"Foundation.":[387],"Dr.":[388,402,420,427,445,464,487,498,509,520,528,541,565,589,613,637,656,675,697,709,721,732,743,754,765,776,787,795,811,919,933,940,954,980,992],"Leary":[389,403,421],"employee":[398,842,887,908,929,950],"$10,000-$49,999":[412,455,474,575],"Proper.":[419],"stock":[423,894,915,936,984],"Drake":[428,446,465,488,499,510,521,529],"Speakers":[460,479,652,671,690,861],"Bureau":[461,480,653,672,691,862],"Harmony":[482,716],"Biosciences.":[483],"institution":[485,496,507,518,695,707,719,730,741,752,763,774,785,866],"research":[491,502,513,524,701,713,725,736,747,758,769,780,791,872],"support":[492,503,514,525,702,714,726,737,748,759,770,781,792,873],"Jazz.":[494,588,693],"Suven.":[505,783],"P&G.":[516],"Axsome.":[527,794],"publishing":[532],"royalties":[533],"publication":[536],"relating":[537,807,1004],"health":[539,809,1006],"care.":[540,810,1007],"Bogan":[542,566,590,614,638,657,676,698,710,722,733,744,755,766,777,788,796,812],"Scientific":[556,580,604,628],"Advisory":[557,581,605,629],"or":[558,582,606,630,805,830,970,985,1002],"Data":[559,583,607,631],"Safety":[560,584,608,632],"Monitoring":[561,585,609,633],"board":[562,586,610,634],"Harmony.":[564,674],"Takeda.":[612,772],"Avadel.":[636,761],"Merck.":[655],"$50,000-$99,999":[685],".":[717],"Philips.":[728],"Fresca.":[750],"intellectual":[799,996],"property":[800,997],"interests":[801,829,998],"discovery":[804,1001],"technology":[806,1003],"non-compensated":[815],"relationship":[816],"Chair":[819],"National":[821],"Foundation":[823],"that":[824],"relevant":[826],"AAN":[828],"activities.":[831],"Judith":[832],"Jaeger":[833],"CognitionMetrics,":[844],"LLC.":[845],"Mr.":[846,868],"Rosenberg":[847,869],"Neurotrials":[875],"Research.":[876],"Caroline":[877,891],"Streicher":[878,892],"Axsome":[889,896,910,917,931,938,952,978,990],"Therapeutics.":[890,897,911,918,932,939,953,979,991],"Miss":[898,912],"Kwak":[899,913],"Bates":[920,934],"Tabuteau":[941,955,981,993],"officer":[969],"member":[971],"Board":[974],"Directors":[976],"ownership":[987],"interest":[988]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-29T00:00:00"}